Proof Hub — Case Studies & Evidence — Behavior Labs | Behavior Labs

Seven case studies. Real decisions. Quantified outcomes — across pharma and medical devices, at every stage of the molecule and device lifecycle.

12 weeksvs. 6-8 months traditional

12-week messaging architecture rebuild

12 weeksvs. 6-8 months traditional payer research

68% formulary access within 90 days

$340Mover 24 months post-LOE through AG timing optimization

$340M franchise revenue preserved

56%from 420 to 186 patients

56% enrollment reduction enabling company independence

19 months earlier510(k) clearance in 7 months vs. 26-36 month De Novo pathway

19-month time-to-market acceleration via split predicate strategy

4 months earlierthan quarterly review process would have flagged

4-month early signal detection protecting 800 patients

60% reductionfrom 11 days to 4 days by fourth molecule

Compounding portfolio intelligence across 4 molecules

Reach out to commission your custom, evidence-grounded assessment